Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on IL‑17
Author:
Affiliation:
1. Department of Oncology, Xiangyang No. 1 People's Hospital, Huibei University of Medicine, Xiangyang, Hubei 441000, P.R. China
Publisher
Spandidos Publications
Subject
Cancer Research,Oncology
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The combination of apatinib and antigen-specific DC-induced T cells exert antitumor effects by potently improving the immune microenvironment of osteosarcoma;Heliyon;2024-08
2. Clinical Progress of Apatinib Monotherapy or Combination with SOX Regimen and PD-1 Monoclonal Antibody in the Treatment of Advanced Gastric Cancer;Journal of Clinical Personalized Medicine;2024
3. PDT for Gastric Cancer — the view from China;Photodiagnosis and Photodynamic Therapy;2023-06
4. Exploration of the Molecular Mechanism of Danzhi Xiaoyao Powder in Endometrial Cancer through Network Pharmacology;Evidence-Based Complementary and Alternative Medicine;2022-06-13
5. EFFICACY ANALYSIS OF APATINIB COMBINED WITH CHEMOTHERAPY IN THE TREATMENT OF ADVANCED SECOND-LINE GASTRIC CANCER;ACTA MEDICA MEDITERR;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3